OakChart

Retractable Technologies Inc

RVPHealthcare·Medical Instruments & Supplies·USA·Nano·AMEX·Nov 11 • 3:59 PM ET

0.5545+0.0005 (0.09%)
2026-11-12 01:23 CET
Market cap
16.59 USD m
Revenue, TTM
33.90 USD m
Net income, TTM
-3.60 USD m
Free cash flow, TTM
-5.11 USD m
EPS diluted, TTM
-0.12
P/E
-
Compare

Price

RVP against its 20, 50 and 200-day averages
2050200
0.550.600.650.700.75132K265KVolumeMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26RVPclose 0.5520-day 0.5750-day 0.64200-day 0.680.55

36.3% under the 52-week high of 0.87 on 18 Nov 2025. 52-week low 0.55 on 10 Nov 2026. Last 15 sessions, 7.1% high to low

Volume 0.57× normal · the line is the 50-bar volume average

Profile

RVP
52-week range, 1% of the way up
0.550.87

Retractable Technologies, Inc. engages in the manufacture and market of safety needle devices for the healthcare industry. It offers injection devices, blood collection devices, and infusion devices. The company was founded by Thomas J. Shaw on May 9, 1994 and is headquartered in Little Elm, TX.

Employees201
IPOMay 04, 2001
Beta1.31
ATR, 14d0.02
Rel volume0.57
Short float0.19%
Insider own59.23%
Inst own8.78%

Snapshot

6 groups

Valuation

Index-
Market Cap16.60M
Enterprise Value-22.21M
Income-3.60M
Sales33.90M
Book/sh2.43
Cash/sh1.33
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees201
IPOMay 04, 2001

Ratios

P/E-
Forward P/E-
PEG-
P/S0.49
P/B0.23
P/C0.42
P/FCF-
EV/EBITDA-
EV/Sales-0.66
Quick Ratio3.74
Current Ratio4.93
Debt/Eq0.01
LT Debt/Eq0.00
Option/ShortYes / Yes

Earnings

EPS (ttm)-0.12
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y-26.10% -14.11%
EPS Y/Y TTM59.85%
Sales Y/Y TTM-11.16%
EPS Q/Q2029.17%
Sales Q/Q-31.07%
Earnings-
EPS/Sales Surpr.- -

Ownership

Insider Own59.23%
Insider Trans0.00%
Inst Own8.78%
Inst Trans3.97%
ROA-2.33%
ROE-4.52%
ROIC-4.61%
Gross Margin1.16%
Oper. Margin-64.09%
Profit Margin-10.62%
SMA20-3.20%
SMA50-13.53%
SMA200-17.87%
Trades-

Technical

Shs Outstand29.94M
Shs Float12.21M
Short Float0.19%
Short Ratio0.70
Short Interest0.02M
52W High0.87 -36.26%
52W Low0.55 0.64%
Volatility3.39% 2.74%
ATR (14)0.02
RSI (14)22.51
Beta1.31
Rel Volume0.57
Avg Volume32.52K
Volume18,381

Performance

Perf Week-2.03%
Perf Month-9.10%
Perf Quarter-18.32%
Perf Half Y-20.79%
Perf YTD-28.18%
Perf Year-34.68%
Perf 3Y-45.09%
Perf 5Y-94.01%
Perf 10Y-77.46%
Recom-
Target Price-
Prev Close0.55
Price0.55
Change %0.09%

Peers

Mkt cap
TickerCompanyMkt cap
BDXBecton Dickinson & Co58.43B
EMBCEmbecta Corp369.99M
MDLNMedline Inc55.47B
ICUIICU Medical Inc4.46B
MLSSMilestone Scientific Inc28.07M
UTMDUtah Medical Products Inc208.06M
TFXTeleflex Incorporated6.20B
KRMDKORU Medical Systems Inc179.60M
MMSIMerit Medical Systems Inc5.28B
CAHCardinal Health Inc64.13B

Insider trading

1 filings
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
SHAW THOMAS JPRESIDENT AND CEONov 14 '25Buy0.775,7314,42415,831,222Nov 17 11:29 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
BUSMEA Bridgeway Ultra-Small Company Market ETFAUM: 111.21M

News

latest 14 of 200

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual-0.14-0.0630.0750.81.630.147-0.242-0.405-0.427-0.1203
Period201720182019202020212022202320242025TTM
EPS, quarterly-0.475-0.0660.124-0.353-0.0050.011-0.08-0.1430.093
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual34.49433.27541.79781.862188.38294.81943.59733.0538.26633.9
Period201720182019202020212022202320242025TTM
Sales, quarterly6.02910.3479.0748.29510.44610.0869.447.1777.201
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual32.66632.66632.67533.95733.48529.93729.93729.93729.93729.937
Period201720182019202020212022202320242025MRQ
Shares, quarterly29.93729.93729.93729.93729.93729.93729.93729.93729.937
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Total Revenue33.9038.2733.0543.6094.82188.3881.8641.8033.27
Cost of Goods Sold Incl. D&A33.5138.2234.0834.4966.5793.0344.8527.6623.05
Gross Profit0.390.05-1.039.1128.2595.3537.0114.1410.22
Selling, General and Administrative Excl. Other21.2420.2720.0820.6029.1122.7612.9411.1711.81
Research and Development0.680.680.670.580.530.900.570.520.62
Other Operating Expense0.880.000.000.000.000.000.000.000.00
Operating Income-21.73-20.22-21.11-11.49-0.8572.6024.072.97-1.59
Interest Expense0.080.090.120.150.170.230.260.170.18
Unusual Expense0.384.09-10.8110.52-2.34-0.86-1.870.00-0.26
Net Income Before Taxes-3.36-12.27-3.52-8.925.1674.9526.073.16-1.35
Income Taxes0.010.298.37-1.910.0818.891.850.01-0.01
Consolidated Net Income-3.37-12.57-11.89-7.015.0856.0627.203.15-1.34
Net Income From Continuing Operations-3.37-12.57-11.89-7.015.0856.0627.203.15-1.34
Net Income-3.60-12.80-12.12-7.244.8555.8226.622.45-2.04
EPS (Recurring)-0.11-0.33-0.660.000.101.610.760.07-0.07
EPS (Basic, Before Extraordinaries)-0.12-0.43-0.40-0.240.151.650.800.07-0.06
EPS (Diluted)-0.12-0.43-0.40-0.240.151.630.800.07-0.06
EBITDA-13.92-12.45-13.54-3.963.7573.8524.903.82-0.70
Non-Operating Income (Expense)18.8212.136.9013.253.841.720.390.350.15
Other After Tax Adjustments0.000.000.000.000.000.002.980.000.00
Stock Option Compensation Expense-0.000.000.008.003.66--0.00
Price To Earnings Ratio----1.854.2513.6420.05-
Price To Sales Ratio0.640.600.620.760.571.264.371.170.58
Gross Margin1.160.12-3.1120.8929.8050.6245.2133.8330.72
Operating Margin-64.09-52.84-63.86-26.35-0.9038.5429.407.11-4.78
Net Margin-10.62-33.44-36.66-16.615.1129.6332.525.85-6.15
Shares Outstanding29.9429.9429.9429.9429.9433.4833.9632.6732.67
Market Capitalization16.5916.5920.6133.2354.02233.99363.1949.0119.44

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue7.207.189.4410.0910.458.309.0710.35
Cost of Goods Sold Incl. D&A6.997.1510.978.4010.558.3011.5710.36
Gross Profit0.210.02-1.531.69-0.11-0.00-2.49-0.01
Selling, General and Administrative Excl. Other5.345.335.235.345.024.674.735.12
Research and Development0.190.170.120.200.160.190.160.17
Other Operating Expense0.020.860.000.000.000.000.000.00
Operating Income-5.15-6.17-6.76-3.65-5.13-4.68-7.22-5.14
Interest Expense0.020.020.020.020.020.020.030.03
Unusual Expense0.18-0.192.77-2.38-3.467.16-9.40-1.45
Net Income Before Taxes2.83-4.22-2.350.37-0.09-10.213.77-1.95
Income Taxes0.000.000.000.000.000.290.00-0.03
Consolidated Net Income2.83-4.23-2.350.37-0.09-10.503.77-1.92
Net Income From Continuing Operations2.83-4.23-2.350.37-0.09-10.503.77-1.92
Net Income2.77-4.28-2.410.31-0.15-10.563.71-1.98
EPS (Recurring)0.10-0.15-0.02-0.05-0.09-0.19-0.10-0.10
EPS (Basic, Before Extraordinaries)0.09-0.14-0.080.01-0.00-0.350.12-0.07
EPS (Diluted)0.09-0.14-0.080.01-0.00-0.350.12-0.07
EBITDA-3.25-4.26-4.61-1.79-3.26-2.79-5.33-3.23
Non-Operating Income (Expense)8.181.777.211.661.611.641.621.76
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Price To Sales Ratio0.640.530.600.670.500.620.620.60
Gross Margin2.950.34-16.2116.72-1.03-0.02-27.49-0.14
Operating Margin-71.46-85.94-71.60-36.23-49.12-56.38-79.58-49.64
Net Margin38.51-59.67-25.493.11-1.39-127.2840.92-19.13
Shares Outstanding29.9429.9429.9429.9429.9429.9429.9429.94
Market Capitalization16.5919.8023.1125.2119.1421.0620.6123.05

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY
Cash & Short Term Investments36.9744.5647.2949.3842.4325.6513.7112.6314.88
Short Term Receivables8.218.7711.8317.4840.7832.916.615.015.11
Inventories17.1919.1917.5820.6820.5910.237.457.556.21
Other Current Assets0.710.750.951.270.700.680.640.640.42
Total Current Assets63.0873.2777.6588.81104.5169.4828.4125.8426.61
Net Property, Plant & Equipment79.1887.3593.48100.1587.9330.8610.7111.0111.35
Total Investments and Advances0.000.000.000.000.000.000.000.000.00
Long-Term Note Receivable-----0.000.050.10-
Deferred Tax Assets-0.008.3921.6020.716.826.667.43-
Other Assets0.370.100.150.180.010.010.010.000.19
Total Assets142.63160.72179.67210.74213.15107.1645.8444.3938.16
Short Term Debt Incl. Current Port. of LT Debt0.370.340.311.381.392.160.340.490.41
Accounts Payable5.344.294.786.4020.4016.265.015.374.96
Income Tax Payable0.010.000.000.064.964.370.020.010.01
Other Current Liabilities3.884.154.284.288.575.122.892.752.52
Total Current Liabilities9.608.789.3812.1435.3227.908.268.627.90
Long Term Debt0.530.901.231.532.854.742.382.723.08
Provision for Risks Charges0.000.000.000.000.000.000.000.000.00
Deferred Tax Liabilities---15.086.852.196.667.43-
Other Liabilities58.1363.8769.7775.4668.9622.440.000.000.00
Total Liabilities68.2673.5580.38104.21113.9857.2817.2918.7710.98
Non-Equity Reserves0.000.000.000.000.000.000.000.000.00
Preferred Stock - Carrying Value0.230.230.230.230.230.260.770.780.78
Common Equity74.1486.9499.06106.3098.9449.6227.7724.8326.39
Total Shareholders Equity74.3887.1799.29106.5499.1749.8828.5425.6127.17
Accumulated Minority Interest0.000.000.000.000.000.000.000.000.00
Total Equity74.3887.1799.29106.5499.1749.8828.5425.6127.17
Total Liabilities & Stockholders Equity142.63160.72179.67210.74213.15107.1645.8444.3938.16
Book Value Per Share2.482.903.313.552.951.460.850.760.81
Tangible Book Value Per Share2.482.903.313.552.951.460.850.760.81
Full-Time Employees201227151198235182140125150
Price to Book Ratio0.230.250.340.502.357.351.760.780.81
Return on Assets-8.28-6.98-3.592.4035.0135.557.62-3.25-9.71
Return on Equity-15.56-12.75-6.814.9475.2369.3611.63-5.08-13.52
Return on Invested Capital-16.77-13.50-6.974.7054.9549.7910.18-4.73-12.35
Quick Ratio4.786.166.415.612.382.122.542.122.58
Current Ratio6.578.348.287.322.962.493.443.003.37

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY
Net Income-3.37-12.57-11.89-21.505.0856.0624.223.15-1.34
Depreciation7.817.777.577.534.601.260.830.850.89
Other Funds (Non Cash)-8.34-3.06-16.1414.024.662.03-1.94-0.14-0.25
Funds from Operations-10.27-7.86-12.06-1.8221.6950.1218.483.86-0.70
Extraordinary Item0.000.000.000.000.000.000.000.000.00
Changes in Working Capital5.310.790.504.59-4.92-17.320.51-1.67-0.49
Income Taxes Payable0.000.00-0.00-0.06-4.900.594.350.01-0.00
Cash from Operating Activities-4.96-7.06-11.562.7716.7732.7919.002.19-1.20
Capital Expenditures-0.15-0.54-1.44-0.85-16.83-58.37-21.05-0.63-0.38
Net Assets From Acquisitions0.000.000.000.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.000.000.000.00
Purchase or Sale of Investments5.356.545.10-9.91-14.37-4.671.72-4.65-2.99
Purchase of Investments-61.20-30.54-0.90-68.48-18.14-4.75-2.24-7.36-2.99
Sale Or Maturity of Investments66.5637.076.0058.573.760.073.972.710.00
Other Uses-0.02-0.020.000.000.000.000.000.000.00
Other Sources0.000.000.000.000.000.000.000.000.00
Cash from Investing Activities5.185.983.66-10.76-31.20-63.04-19.33-5.28-3.37
Cash Dividends Paid-0.23-0.23-0.23-0.23-0.25-3.82-0.22-0.22-0.22
Change in Capital Stock0.000.000.00-1.11-8.71-6.420.440.000.00
Repurchase of Common Pref Stock0.000.000.00-1.11-8.72-6.47-0.480.000.00
Sale of Common Pref Stock0.000.000.000.000.010.050.920.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.35-0.34-0.30-0.28-0.28-0.271.10-0.41-0.45
Change in Long Term Debt-0.35-0.34-0.30-0.28-0.28-0.271.10-0.41-0.45
Issuance of Long Term Debt0.000.000.000.000.000.001.360.000.00
Reduction of Long Term Debt-0.35-0.34-0.30-0.28-0.28-0.27-0.26-0.41-0.45
Net Financing Active Other Cash Flow0.000.000.002.5614.2452.3710.640.000.00
Other Financing Activities Uses0.000.000.000.000.000.000.000.000.00
Cash from Financing Activities-0.63-0.57-0.540.944.9941.8411.96-0.63-0.67
Net Change in Cash-0.40-1.65-8.43-7.05-9.4411.6011.63-3.71-5.23
Free Cash Flow-5.11-7.60-13.001.91-0.06-25.57-2.051.56-1.58
Preferred Dividends (Cash Flow)--0.23-0.23-0.23-0.25-3.82-0.22-0.22-0.22
Price to Free Cash Flow---19.76---36.50-
Deferred Taxes & Investment Tax Credit-0.008.39-1.877.35-9.23-4.630.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments39.8735.6236.9733.9533.0535.71
Short Term Receivables9.347.298.219.108.756.05
Inventories15.9316.4317.1920.3920.4521.18
Other Current Assets0.780.620.710.690.740.72
Total Current Assets65.9259.9663.0864.1363.0063.66
Net Property, Plant & Equipment75.4777.3179.1882.2484.0185.55
Total Investments and Advances0.000.000.000.000.000.00
Other Assets0.310.330.370.070.080.09
Total Assets141.69137.60142.63146.43147.09149.31
Short Term Debt Incl. Current Port. of LT Debt0.490.480.370.370.360.35
Accounts Payable6.705.385.344.574.064.72
Income Tax Payable0.010.010.010.010.000.00
Other Current Liabilities6.174.573.884.684.574.42
Total Current Liabilities13.3710.459.609.638.999.50
Long Term Debt0.340.430.530.620.720.81
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities55.1356.6258.1359.4060.9262.39
Total Liabilities68.8367.5068.2669.6570.6272.70
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.230.230.230.230.230.23
Common Equity72.6369.8674.1476.5576.2476.38
Total Shareholders Equity72.8770.0974.3876.7876.4776.61
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity72.8770.0974.3876.7876.4776.61
Total Liabilities & Stockholders Equity141.69137.60142.63146.43147.09149.31
Book Value Per Share2.432.332.482.562.552.55
Tangible Book Value Per Share2.432.332.482.562.552.55
Full-Time Employees--201---
Price to Book Ratio0.230.280.300.330.250.24
Return on Assets-2.33-4.38-8.28-4.24-5.68-14.03
Return on Equity-4.52-8.57-15.56-8.05-10.80-25.89
Return on Invested Capital3.87-5.99-3.130.48-0.11-13.56
Quick Ratio3.744.174.784.544.734.47
Current Ratio4.935.746.576.667.016.70

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income2.83-4.23-2.350.37-0.09-10.50
Depreciation1.901.902.141.871.871.88
Other Funds (Non Cash)-1.13-0.81-3.23-3.18-2.325.67
Funds from Operations-2.76-3.13-3.44-0.94-0.54-2.94
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital1.031.762.84-0.32-3.201.47
Income Taxes Payable-0.000.000.000.000.00-0.00
Cash from Operating Activities-1.73-1.37-0.60-1.26-3.73-1.48
Capital Expenditures-0.03-0.01-0.03-0.09-0.33-0.09
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments1.811.72-0.071.893.870.85
Purchase of Investments-18.63-12.32-30.11-0.14-0.13-0.15
Sale Or Maturity of Investments20.4414.0530.042.034.001.00
Other Uses0.02-0.02-0.020.000.000.00
Other Sources0.000.000.000.000.000.00
Cash from Investing Activities1.811.69-0.111.803.540.76
Cash Dividends Paid-0.06-0.06-0.06-0.06-0.06-0.06
Preferred Dividends (Cash Flow)-0.06-0.06-0.06-0.06-0.06-0.06
Change in Capital Stock0.000.000.000.000.000.00
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock0.000.000.000.000.000.00
Proceedsfrom Stock Options0.000.000.000.000.000.00
Issuance or Reduction of Debt, Net-0.09-0.09-0.09-0.08-0.08-0.08
Change in Long Term Debt-0.09-0.09-0.09-0.08-0.08-0.08
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.09-0.09-0.09-0.08-0.08-0.08
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities-0.20-0.15-0.14-0.14-0.14-0.14
Net Change in Cash-0.120.18-0.860.40-0.34-0.85
Free Cash Flow-1.76-1.37-0.62-1.35-4.07-1.56

Revenue breakdown

Blood Collection Products2024: 1.43M 2025: 1.37M
Consolidation, Policy2024: -189.00K
EasyPoint Needles2024: 8.95M 2025: 11.94M
License2024: 189.00K
Other Products2024: 45.85K 2025: 43.63K
Syringes2024: 22.63M 2025: 24.91M
United States2024: 33.05M 2025: 38.27M

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-300.19%0.0M12.2M30.57K
2026-10-150.22%0.0M12.2M30.31K
2026-09-300.45%0.1M12.2M26.38K
2026-09-150.51%0.1M12.2M40.17K
2026-08-310.80%0.1M12.2M54.93K
2026-08-140.17%0.0M12.2M66.21K
2026-07-310.19%0.0M12.2M74.96K
2026-07-150.14%0.0M12.2M81.23K
2026-06-300.16%0.0M12.2M87.67K
2026-06-150.27%0.0M12.2M80.80K
2026-05-290.22%0.0M12.2M70.95K
2026-05-150.36%0.0M12.2M60.77K
2026-04-300.31%0.0M12.2M58.13K
2026-04-150.24%0.0M12.2M60.43K
2026-03-310.62%0.1M12.2M53.38K
2026-03-130.63%0.1M12.2M51.33K
2026-02-270.77%0.1M12.2M48.08K
2026-02-130.26%0.0M12.2M50.09K
2026-01-300.14%0.0M12.2M46.89K
2026-01-150.17%0.0M12.2M99.62K

Option chain

expiry 2026-11-20
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
call2.500.000.700.000.0000.000.000.0000.0000.000
call5.000.004.900.000.0000.000.000.0000.0000.000
call7.500.000.750.000.0000.000.000.0000.0000.000
put2.500.004.900.000.0000.000.000.0000.0000.000
put5.002.206.900.000.0000.000.000.0000.0000.000
put7.504.509.500.000.0000.000.000.0000.0000.000

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-09-308-KCurrent report2026-09-30SEC
2026-08-148-KCurrent report2026-08-14SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-06-308-KCurrent report2026-06-30SEC
2026-05-158-KCurrent report2026-05-15SEC
2026-05-1510-QQuarterly report pursuant to Section 13 or 15(d)2026-03-31SEC
2026-05-138-KCurrent report2026-05-08SEC
2026-04-108-KCurrent report2026-04-09SEC
2026-03-278-KCurrent report2026-03-27SEC
2026-03-2710-KAnnual report pursuant to Section 13 or 15(d)2025-12-31SEC
2026-03-27DEFA14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934SEC
2026-03-27DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-05-08SEC
2025-12-308-KCurrent report2025-12-30SEC
2025-11-174Statement of changes in beneficial ownership of securities2025-11-14SEC
2025-11-148-KCurrent report2025-11-14SEC
2025-11-1410-QQuarterly report pursuant to Section 13 or 15(d)2025-09-30SEC
2025-11-134Statement of changes in beneficial ownership of securities2025-11-11SEC
2025-11-064Statement of changes in beneficial ownership of securities2025-11-05SEC
2025-10-314Statement of changes in beneficial ownership of securities2025-10-30SEC
2025-10-294Statement of changes in beneficial ownership of securities2025-10-28SEC
2025-10-284Statement of changes in beneficial ownership of securities2025-10-27SEC
2025-10-274Statement of changes in beneficial ownership of securities2025-10-23SEC
2025-10-234Statement of changes in beneficial ownership of securities2025-10-22SEC
2025-10-154Statement of changes in beneficial ownership of securities2025-10-14SEC
2025-10-094Statement of changes in beneficial ownership of securities2025-10-08SEC
2025-09-304Statement of changes in beneficial ownership of securities2025-09-29SEC
2025-09-308-KCurrent report2025-09-30SEC
2025-09-254Statement of changes in beneficial ownership of securities2025-09-24SEC
2025-09-244Statement of changes in beneficial ownership of securities2025-09-23SEC
2025-09-044Statement of changes in beneficial ownership of securities2025-09-03SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-100000
2026-090000
2026-080000
2026-070000
2026-060000
2026-050000
2026-040000
2026-030000
2026-020000
2026-010000
2025-120000
2025-1110.70K300

Institutional holders

Manager% owned
VANGUARD CAPITAL MANAGEMENT LLC1.94%
Eversept Partners, LP1.94%
RENAISSANCE TECHNOLOGIES LLC1.47%
BlackRock, Inc.0.81%
GEODE CAPITAL MANAGEMENT, LLC0.39%
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.30%
CITADEL ADVISORS LLC0.29%
VANGUARD FIDUCIARY TRUST CO0.28%
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.26%
STATE STREET CORP0.20%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.38%
VANGUARD EXTENDED MARKET INDEX FUND0.57%
Ultra-Small Company Market Fund0.21%
Fidelity Extended Market Index Fund0.18%
Fidelity Total Market Index Fund0.11%
Fidelity Series Total Market Index Fund0.05%
Omni Small-Cap Value Fund0.03%
Guggenheim Active Allocation Fund0.00%

OakChart. RVP. Cached 15 minutes.

Some panels did not load: ratings.